1
Hartmut Schirok, Joachim Mittendorf, Johannes Peter Stasch, Frank Wunder, Friederike Stoll, Karl Heinz Schlemmer: Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivatives as stimulators of guanylate cyclase for cardiovascular disorders. Bayer Intellectual Property, Karen B King, November 13, 2012: US08309551 (19 worldwide citation)

The present application relates to novel azabicyclic compounds, processes for their preparation, their use alone or in combinations for the treatment and/or prevention of diseases, and their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment a ...


2
Mario Jeske, Ingo Flamme, Friederike Stoll, Hartmut Beck, Metin Akbaba: Substituted dihydropyrazolones and their use. Bayer Pharma Aktiengesellschaft, November 29, 2011: US08067407 (6 worldwide citation)

The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and ...


3
Rudolf Schohe Loop, Reinhold Welker, Arnold Paessens, Marcus Bauser, Friederike Stoll, Frank Dittmer, Kerstin Henninger, Daniela Paulsen, Dieter Lang: Substituted pyrazolamides and their use. AiCuris & Co KG, Morrison & Foerster, November 20, 2012: US08314089 (3 worldwide citation)

The present invention relates to novel substituted pyrazolamides, methods for their preparation, their use for the treatment and/or prophylaxis of diseases, as well as their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially of retroviral diseases, in ...


4
Kai Thede, Ingo Flamme, Felix Oehme, Jens Kerim Ergüden, Friederike Stoll, Joachim Schuhmacher, Hanno Wild, Peter Kolkhof, Hartmut Beck, Metin Akbaba, Mario Jeske: Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors. Bayer Intellectual Property, Karen B King, September 3, 2013: US08524699 (2 worldwide citation)

The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and ...


5
Kai Thede, Ingo Flamme, Felix Oehme, Jens Kerim Ergüden, Friederike Stoll, Hanno Wild, Peter Kolkhof, Hartmut Beck, Mario Jeske: Substituted dipyridyl-dihydropyrazolones and use thereof. Bayer Intellectual Property, Karen B King, December 17, 2013: US08609698 (2 worldwide citation)

The present application relates to novel substituted dipyridyldihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovasc ...


6
Walter Hübsch, Michael Hahn, Alexandros Vakalopoulos, Volkhart Min Jian Li, Frank Wunder, Johannes Peter Stasch, Karl Heinz Schlemmer, Friederike Stoll, Niels Lindner: Substituted 8-alkoxy-2-aminotetralin derivatives, and use thereof. Bayer Intellectual Property, Karen B King, March 18, 2014: US08673903 (2 worldwide citation)

The present application relates to novel substituted 8-alkoxy-2-aminotetraline derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for t ...


7
Kai Thede, Ingo Flamme, Felix Oehme, Jens Kerim Ergüden, Friederike Stoll, Joachim Schuhmacher, Hanno Wild, Peter Kolkhof, Hartmut Beck, Jörg Keldenich, Metin Akbaba, Mario Jeske: Substituted dihydropyrazolones for treating cardiovascular and hematological diseases. Bayer Intellectual Property, Karen B King, February 18, 2014: US08653111 (2 worldwide citation)

The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and ...


8
Thomas Lampe, Michael Hahn, Johannes Peter Stasch, Karl Heinz Schlemmer, Frank Wunder, Sherif El Sheikh, Volkhart Min Jian Li, Eva Maria Becker Pelster, Friederike Stoll, Andreas Knorr: Substituted 3-phenylpropionic acids and the use thereof. Bayer Intellectual Property, Buchanan Ingersoll & Rooney PC, April 28, 2015: US09018414 (1 worldwide citation)

The present application relates to novel 3-phenylpropionic acid derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases and to their use for preparing medicaments for the treatment and/or prevention of diseases, in particular for the treatment an ...


9
Thomas Lampe, Michael G Hahn, Johannes Peter Stasch, Karl Heinz Schlemmer, Frank Wunder, Sherif El Sheikh, Volkhart Min Jian Li, Eva Maria Becker, Friederike Stoll, Andŕeas Knorr, Peter Kolkhof, Elisabeth Woltering: Substituted 1-benzylcycloalkylcarboxylic acids and the use thereof. Bayer Intellectual Property, Buchanan Ingersoll & Rooney PC, April 28, 2015: US09018258 (1 worldwide citation)

The present application relates to novel substituted 1-benzylcycloalkylcarboxylic acid derivatives, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially ...


10
Mario Jeske, Ingo Flamme, Friederike Stoll, Hartmut Beck, Metin Akbaba: Substituted dihydropyrazolones and their use. Bayer Intellectual Property, Karen B King, November 12, 2013: US08580778 (1 worldwide citation)

The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and ...